FDC
Back to Income Statement
|
FDC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr |
What is the latest Consolidated Net Profit of FDC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹267 Cr |
| Mar2024 | ₹305 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹216 Cr |
| Mar2021 | ₹301 Cr |
How is Consolidated Net Profit of FDC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹267 Cr | -12.55 | |
| Mar2024 | ₹305 Cr | 57.22 | |
| Mar2023 | ₹194 Cr | -10.33 | |
| Mar2022 | ₹216 Cr | -28.19 | |
| Mar2021 | ₹301 Cr | - | |
Compare Consolidated Net Profit of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,569.4 Cr | -0.9% | -15.8% | -27.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -0.9% |
-15.8% |
-27.5% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses